References in this annual report on Form 10-K to “Predictive”, “Company”, “we”, “us”, and “our” refer to the business of Predictive Oncology Inc. (NASDAQ: POAI) and its wholly owned subsidiaries. Cautionary Statement Concerning Forward-Looking Statements This Annual Report on Form 10-K contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements represent our expectations and beliefs concerning future results or events, based on information available to us on the date of the filing of this Form 10-K, and are subject to various risks and uncertainties. Factors that could cause actual results or events to differ materially from those referenced in the forward-looking statements are listed in Part I, Item 1A. Risk Factors and in Part II, Item 7.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 728K | - | - | - | - | - |
| Net Income | -84M | -13M | -14M | -26M | -20M | -26M |
| EPS | $-139.72 | $-34.80 | $-52.20 | $-2,094.00 | $-108.00 | $663.00 |
| Free Cash Flow | -8.0M | -11M | -12M | -13M | -13M | -13M |
| ROIC | -260.6% | -1882.7% | -66.4% | -118.2% | -48.8% | -172.8% |
| Gross Margin | 50.2% | - | - | - | - | - |
| Debt/Equity | 0.00 | -10.52 | 0.35 | 0.01 | 0.02 | 3.90 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -10M | -11M | -12M | -26M | -20M | -25M |
| Operating Margin | -1421.4% | - | - | - | - | - |
| ROE | 0.0% | -313.9% | -169.1% | -118.2% | -48.8% | -1000.4% |
| Shares Outstanding | 3M | 0M | 1M | 0M | 0M | 0M |
Axe Compute Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
At current prices, the estimated annualized return to fair value is -27.2%.
Axe Compute Inc. (AGPU) has a 5-year average return on invested capital (ROIC) of -101.6%. This is below average and may indicate limited pricing power.
Axe Compute Inc. (AGPU) has a market capitalization of $12M. It is classified as a small-cap stock.
Axe Compute Inc. (AGPU) does not currently pay a regular dividend.
Axe Compute Inc. (AGPU) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, within the Healthcare sector.
Axe Compute Inc. (AGPU) generated $-11 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Axe Compute Inc. (AGPU) reported earnings per share (EPS) of $-34.80 in its most recent fiscal year.
Axe Compute Inc. (AGPU) has a return on equity (ROE) of -313.9%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 15 years of financial data for Axe Compute Inc. (AGPU), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Axe Compute Inc. (AGPU) has a book value per share of $-0.56, based on its most recent annual SEC filing.